Technical Analysis for CYAD - Celyad SA

Grade Last Price % Change Price Change
grade F 10.0 -1.86% -0.19
CYAD closed down 1.86 percent on Friday, September 20, 2019, on 36 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical CYAD trend table...

Date Alert Name Type % Chg
Calm After Storm Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.86%
Calm After Storm Range Contraction -1.86%
Narrow Range Bar Range Contraction -1.86%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.57%
Calm After Storm Range Contraction -1.57%
Narrow Range Bar Range Contraction -1.57%

Older signals for CYAD ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Celyad SA, formerly Cardio3 Biosciences SA is a Belgium-based drug developing company. The Company develops stem cell-based therapies for cardiovascular disease. The Company focuses on developing regenerative therapies to treat illnesses where cardiac tissue is lost due to chronic or acute injury. The Company's product, C-Cure, allows the differentiation of a patient's own cells into cardiopoeitic cells which grow into new heart cells and repair heart muscle. C-Cure consists of autologous adult stem cells guided in vitro to the cardiac lineage before implantation in the failing heart. Furthermore, the Company is involved in the field of immuno-oncology, through its subsidiary, OnCyte.
Biotechnology Life Sciences Biology Stem Cells Cardiovascular Disease Stem Cell Therapy Induced Stem Cells Adult Stem Cell
Is CYAD a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 28.89
52 Week Low 9.04
Average Volume 36,112
200-Day Moving Average 18.0079
50-Day Moving Average 12.4757
20-Day Moving Average 12.0127
10-Day Moving Average 11.024
Average True Range 0.8618
ADX 28.27
+DI 16.6783
-DI 37.2325
Chandelier Exit (Long, 3 ATRs ) 12.3946
Chandelier Exit (Short, 3 ATRs ) 11.625399999999999
Upper Bollinger Band 15.1733
Lower Bollinger Band 8.8521
Percent B (%b) 0.18
BandWidth 52.620976
MACD Line -0.7318
MACD Signal Line -0.4356
MACD Histogram -0.2961
Fundamentals Value
Market Cap 95.25 Million
Num Shares 9.53 Million
EPS -2.70
Price-to-Earnings (P/E) Ratio -3.70
Price-to-Sales 41.08
Price-to-Book 6.10
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.33
Resistance 3 (R3) 10.35 10.25 10.28
Resistance 2 (R2) 10.25 10.17 10.25 10.26
Resistance 1 (R1) 10.13 10.12 10.08 10.11 10.24
Pivot Point 10.03 10.03 10.01 10.03 10.03
Support 1 (S1) 9.91 9.95 9.86 9.89 9.76
Support 2 (S2) 9.81 9.90 9.81 9.74
Support 3 (S3) 9.69 9.81 9.73
Support 4 (S4) 9.67